160
http://www.DGS-PraxisLeitlinien.deNr.
Nachweis
97
Ferrell BR, Juarez G, Borneman T. Use of routine and breakthrough analgesia in home
care. Oncology Nursing Forum 1999; 26: 1655-1661.
98
Fine PG, Busch MA. Characterization of breakthrough pain by hospice patients and their
caregivers. Journal of Pain and Symptom Management 1998; 16(3): 179-183.
99
Fine PG, Herr KA. Efficacy, safety and tolerability of pharmacotherapy for management
of persistent pain in older persons. Annals of Long-term Care: Clinical Care and Aging
2006; 14(3): 25-33.
100
Fine PG, Messina J, Xie F, Rathmell J. Long-term safety and tolerability of fentanyl buccal
tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic
pain: an 18-month study. J Pain Symptom Manage 2010; 40(5): 747-760.
101
Fine PG. The diagnosis and treatment of breakthrough pain. Oxford University Press,
2008.
102
Fine PG. The evolving and important role of anesthesiology in palliative care. Anesthe-
sia and Analgesia 2005; 100: 183-188.
103
Finn AL, Vasisht N, Stark JG, Gever LN, Tagarro I. Dose proportionality and pharmacoki-
netics of fentanyl buccal soluble film in healthy subjects: a phase I, open-label, three-
period, crossover study. Clin Drug Investig 2012; 32(1): 63-71.
104
Fisher A, Watling M, Smith A, Knight A. Pharmacokinetics and relative bioavailability of
fentanyl pectin nasal spray 100-800 mg in healthy volunteers. Int J Clin Pharmacol Ther
2010; 48 (12): 860-867.
105
Fisher HB, Peters TM, Fleming IM, Else TA. Peripheral nerve catheterization in the ma-
nagement of terminal cancer pain. Regional Anesthesia 1996; 21: 482-485.
106
Foley KM. Acute and chronic cancer pain syndromes. In: Doyle D, Hanks G, Cherny N,
Calman K (Hrsg.), Oxford Textbook of Palliative Medicine (3. Aufl., pp. 298-316). Oxford:
Oxford University Press 2004.
107
Fortner BV, Demarco G, Irving G, Ashley J, Keppler G, Chavez J, Munk J. Description and
predictors of direct and indirect costs of pain reported by cancer patients. Journal of
Pain and Symptom Management 2003; 25(1): 9-18.
108
Fortner BV, Okon TA, Portenoy RK. A survey of pain-related hospitalizations, emergen-
cy department visits, and physician office visits reported by cancer patients with and
without history of breakthrough pain. Journal of Pain 2002; 3(1): 38-44.
109
Fourney DR, Schomer DF, Nader R, Chlan-Fourney J, Suki D, Ahrar K, Rhines LD,
Gokaslan ZL. Percutaneous vertebroplasty and kyphoplasty for painful vertebral body
fractures in cancer patients. Journal of Neurosurgery 2003; 98 (Suppl): 21-30.
110
Freye E, Levy JV, Braun D. Effervescent morphine results in faster relief of breakthrough
pain in patients compared to immediate release morphine sulfate tablet. Pain Practice
2007; 7: 324-331.
111
Friedrichsdorf SJ, Finney D, Bergin M, Stevens M, Collins JJ. Breakthrough pain in child-
ren with cancer. J Pain Symptom Manage. 2007; 34(2): 209-216.
Literaturverzeichnis